However, the levels of IL-6 were lower compared to those observed in sepsis (983 pg/mL), in non-COVID ARDS (460 pg/mL), and in CAR-T CRS (3110 pg/mL) (36), suggesting that the systemic inflammation during COVID-19 is less robust (37–39). This evidence concerns the gene IL6 and Sepsis.